By: Susan Sumrell

In late November, HRSA’s Office of Pharmacy Affairs relased three new Program Notices, which clarify current HRSA Policy.   The program notices focus on the non-discrimination policy, penny pricing policy, and manufacturer audits.   Please take a minute to review these notices to ensure you have the latest information on these policies.   For more on these new notices and other 340B information, check out the HRSA Office of Pharmacy Affairs website.